These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9212801)

  • 21. [Molecular diagnosis of the Hippel-Lindau syndrome].
    Neumann HP; Brauch H
    Dtsch Med Wochenschr; 1995 Oct; 120(41):1416. PubMed ID: 7555669
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of a late-onset autosomal dominant precancerous disease on the knowledge and attitudes of a large kindred.
    Yuen J; Jewell R; Lamiell MJ; Hsia YE
    Birth Defects Orig Artic Ser; 1984; 20(6):135-46. PubMed ID: 6535592
    [No Abstract]   [Full Text] [Related]  

  • 23. Unintended diagnosis of Von Hippel Lindau syndrome using Array Comparative Genomic Hybridization (CGH): counseling challenges arising from unexpected information.
    Hogan J; Turner A; Tucker K; Warwick L
    J Genet Couns; 2013 Feb; 22(1):22-6. PubMed ID: 22895882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for von Hippel-Lindau disease by DNA polymorphism analysis.
    Glenn GM; Linehan WM; Hosoe S; Latif F; Yao M; Choyke P; Gorin MB; Chew E; Olfield E; Manolatos C
    JAMA; 1992 Mar; 267(9):1226-31. PubMed ID: 1347089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of clinical care for familial endocrine tumor syndromes in Japan.
    Sakurai A; Uchino S; Takami H
    Endocr J; 2005 Dec; 52(6):757-62. PubMed ID: 16410669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Hippel-Lindau syndrome is often misdiagnosed and its frequency underestimated].
    Neumann HP
    Orv Hetil; 1996 Jun; 137(22):1191-5. PubMed ID: 8757100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting von Hippel-Lindau syndrome: the future is now.
    Matin SF; Jonasch E
    Future Oncol; 2006 Jun; 2(3):321-3. PubMed ID: 16787109
    [No Abstract]   [Full Text] [Related]  

  • 28. [The current clinical status of kidney cancers in patients with the VHL disease in Japan: a nationwide epidemiological survey].
    Shuin T; Shinohara N; Yao M; Yamasaki I; Tamura K; Kamada M
    Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):552-6. PubMed ID: 22876660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 65 YEARS OF THE DOUBLE HELIX: Could Watson and Crick have envisioned the true impact of their discovery?
    Sussman I
    Endocr Relat Cancer; 2018 Aug; 25(8):E9-E11. PubMed ID: 29980643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Hippel-Lindau disease.
    Richard S; Graff J; Lindau J; Resche F
    Lancet; 2004 Apr; 363(9416):1231-4. PubMed ID: 15081659
    [No Abstract]   [Full Text] [Related]  

  • 31. Attitudes of von Hippel-Lindau disease patients towards presymptomatic genetic diagnosis in children and prenatal diagnosis.
    Levy M; Richard S
    J Med Genet; 2000 Jun; 37(6):476-8. PubMed ID: 10928862
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary: Von Hippel-Lindau disease: A clinical and scientific review.
    Abedalthagafi M
    Eur J Hum Genet; 2022 Oct; 30(10):1103-1104. PubMed ID: 36221028
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer genetics, genetic counseling, and cancer control. Part II.
    Lynch HT; Lynch JF
    Nebr Med J; 1975 Mar; 60(3):65-7. PubMed ID: 1134607
    [No Abstract]   [Full Text] [Related]  

  • 34. Von Hippel-Lindau disease and multispecialist team.
    Pavesi G; Feletti A; Ferrara AM; Anglani M; Scarpa B; Schiavi F; Boaretto F; Zovato S; Taschin E; Gardi M; Zanoletti E; Piermarocchi S; Murgia A; Opocher G;
    J Neurosurg Sci; 2021 Apr; 65(2):213-215. PubMed ID: 32347679
    [No Abstract]   [Full Text] [Related]  

  • 35. Von Hippel-Lindau: a relentless disorder.
    Jenson CE
    RN; 1993 Aug; 56(8):36-40; quiz 41. PubMed ID: 8362185
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent problems in genetic counseling.
    Okura K
    Jinrui Idengaku Zasshi; 1974 Jun; 19(1):106. PubMed ID: 4476821
    [No Abstract]   [Full Text] [Related]  

  • 37. Organic synthesis: current status in Japan.
    Noyori R
    Science; 1992 Oct; 258(5082):584-5. PubMed ID: 17748891
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status of clinical diagnosis and DNA test of von Hippel-Lindau disease in Japan].
    Shuuin T; Yao M; Kanno H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):938-44. PubMed ID: 9212801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
    Hes FJ; van der Luijt RB
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.